Related references
Note: Only part of the references are listed.Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial
Scott C. Woller et al.
BLOOD ADVANCES (2022)
Impact of COVID-19 and COVID-19 vaccination on high-risk patients with antiphospholipid syndrome: a nationwide survey
Vittorio Pengo et al.
RHEUMATOLOGY (2022)
Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines
Daniele Pastori et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management
Zara Sayar et al.
THROMBOSIS RESEARCH (2021)
Outcomes in patients with nontriple antiphospholipid syndrome (APS) anticoagulated with rivaroxaban
Thura Win Htut et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2021)
Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure
Vittorio Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Antithrombotic Therapy for VTE Disease Second Update of the CHEST Guideline and Expert Panel Report
Scott M. Stevens et al.
CHEST (2021)
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Frank L. J. Visseren et al.
EUROPEAN HEART JOURNAL (2021)
2019 ESC Guidelines for the dignosis and management of acute pulmonary embolism development Toed in colaboration with the European Respiratory Society (ERS)
Stavros Konstantinides et al.
EUROPEAN HEART JOURNAL (2020)
The (non-)sense of detecting anti-cardiolipin and anti-β2glycoprotein I IgM antibodies in the antiphospholipid syndrome
Walid Chayoua et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Antiphospholipid syndrome: Diagnosis and management in the obstetric patient
Erol Arslan et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2020)
Antiphospholipid syndrome
Lisa R. Sammaritano
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2020)
British Society for Haematology Guidelines on Investigation and Management of Antiphospholipid syndrome (vol 157, pg 47, 2012)
Deepa R. J. Arachchillage et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Tetra positive thrombotic antiphospholipid syndrome: Major contribution of anti-phosphatidyl-serine/prothrombin antibodies to lupus anticoagulant activity
Maria Grazia Cattini et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Catastrophic Antiphospholipid Syndrome as the Initial Presentation of Waldenstrom Macroglobulinemia
Dong Kim et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis
Armando Tripodi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Testing for antiphospholipid antibodies: Advances and best practices
Katrien M. J. Devreese
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)
Management of anticoagulant-refractory thrombotic antiphospholipid syndrome
Hannah Cohen et al.
Lancet Haematology (2020)
Beyond current concepts in anti-phospholipid syndrome: The 16th International Congress on Anti-phospholipid Antibodies (ICAPA) in Manchester
Cecilia Beatrice Chighizola et al.
AUTOIMMUNITY REVIEWS (2020)
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
Stephane Zuily et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends
Hannah Cohen et al.
LUPUS (2020)
Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis Update of the guidelines for lupus anticoagulant detection and interpretation
Katrien M. J. Devreese et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
An update on the management of antiphospholipid syndrome
Mia Rodziewicz et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2020)
EULAR recommendations for the management of antiphospholipid syndrome in adults
Maria G. Tektonidou et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort
Massimo Radin et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Recurrent Thrombosis With Direct Oral Anticoagulants in Antiphospholipid Syndrome: A Systematic Literature Review and Meta-analysis
Jorge Sanchez-Redondo et al.
CLINICAL THERAPEUTICS (2019)
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome A Randomized Noninferiority Trial
Josep Ordi-Ros et al.
ANNALS OF INTERNAL MEDICINE (2019)
Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndrome
Naoki Ohnishi et al.
RHEUMATOLOGY (2019)
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome
Vittorio Pengo et al.
BLOOD (2018)
Diagnosis and Management of the Antiphospholipid Syndrome
David Garcia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Clinical utility of the global anti-phospholipid syndrome score for risk stratification: a pooled analysis
Savino Sciascia et al.
RHEUMATOLOGY (2018)
Extra-criteria manifestations of antiphospholipid syndrome: Risk assessment and management
Massimo Radin et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2018)
Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis
Virginie Dufrost et al.
AUTOIMMUNITY REVIEWS (2018)
Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of Non-criteria Antiphospholipid Antibodies
Navid Zohoury et al.
JOURNAL OF RHEUMATOLOGY (2017)
Direct oral anticoagulants: an alternative treatment for thrombotic antiphospholipid syndrome?
A. S. Resseguier et al.
LUPUS (2017)
Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances
Savino Sciascia et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study
Gabriele Saccone et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)
Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry
Ignasi Rodriguez-Pinto et al.
AUTOIMMUNITY REVIEWS (2016)
Antiphospholipid syndrome
M. Khamashta et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2016)
Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH
A. Tripodi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial
Hannah Cohen et al.
Lancet Haematology (2016)
β2GP1, Anti-β2GP1 Antibodies and Platelets: Key Players in the Antiphospholipid Syndrome
Yik C. Ho et al.
ANTIBODIES (2016)
The relevance of non-criteria clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features
Mirhelen M. Abreu et al.
AUTOIMMUNITY REVIEWS (2015)
Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies
Laurent Arnaud et al.
AUTOIMMUNITY REVIEWS (2015)
Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)
Johanna Gebhart et al.
BLOOD (2015)
Interference of C-reactive protein with clotting times
Katrien M. J. Devreese et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2015)
Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: An international and collaborative meta-analysis
Laurent Arnaud et al.
AUTOIMMUNITY REVIEWS (2014)
Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS)
Maria J. Cuadrado et al.
RHEUMATOLOGY (2014)
Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review
David Garcia et al.
BLOOD (2013)
Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative
Emmanuel Coloma Bazan et al.
IMMUNOLOGIC RESEARCH (2013)
Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
GAPSS: the Global Anti-Phospholipid Syndrome Score
Savino Sciascia et al.
RHEUMATOLOGY (2013)
Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events
Kotaro Otomo et al.
ARTHRITIS AND RHEUMATISM (2012)
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies
Michael D. Lockshin et al.
ARTHRITIS AND RHEUMATISM (2012)
Efficacy and safety of long-term low molecular weight heparin in patients with antiphospholipid syndrome
Jose Antonio Vargas-Hitos et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study
Vittorio Pengo et al.
BLOOD (2011)
First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss
Kate Bramham et al.
BLOOD (2011)
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies
G. Ruiz-Irastorza et al.
LUPUS (2011)
Pathogenesis of antiphospholipid syndrome: understanding the antibodies
Pier Luigi Meroni et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of a series of 280 patients from the CAPS Registry
Ricard Cervera et al.
JOURNAL OF AUTOIMMUNITY (2009)
Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification
A. Ruffatti et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Anticoagulation treatment withdrawal in primary antiphospholipid syndrome when anticardiolipin antibodies become negative
J. Criado-Garcia et al.
REVISTA CLINICA ESPANOLA (2008)
EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics
G. Bertsias et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies
Guillermo Ruiz-Irastorza et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Aspirin for primary thrombosis prevention in the antiphospholipid syndrome - A randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals
Doruk Erkan et al.
ARTHRITIS AND RHEUMATISM (2007)
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients
Paolo Prandoni et al.
HAEMATOLOGICA (2007)
Detection of shortened activated partial thromboplastin times: An evaluation of different commercial reagents
Edwin ten Boekel et al.
THROMBOSIS RESEARCH (2007)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome(WAPS)
G Finazzi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome
MA Crowther et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature
M Galli et al.
BLOOD (2003)
Clinical and epidemiological aspects in the antiphospholipid syndrome
R Cervera et al.
IMMUNOBIOLOGY (2003)
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines
RA Asherson et al.
LUPUS (2003)
Share Paper
